The following research report provides an array of treatment options for Essential Thrombocythemia, Polycythemia Vera, and Myelofibrosis, including interferon therapy, by top experts in the field of Myeloproliferative Neoplasms. Drs. Claire Harrison, Hans Hasselbalch, Richard Silver, and Ruben Mesa share their expertise in clinical evaluations of MPN’s and possible treatments, depending on risk stratification and symptomatic burden.
Thanks to MPN Forum for sharing this report.
Click here for – Interferon treatment for MPN’s
